- October 26, 2022The Article related to phenylsulfonyl carbamidoyl quinolone preparation topoisomerase inhibitor structure activity relationship, topoisomerase phenylsulfonyl carbamidoyl quinolone docking antitumor drug…
- October 26, 2022The Article related to review imatinib bosutinib anticancer bcr abl chronic myelogenous leukemia, atp-competitive inhibitors, bcr-abl, t315i mutation, chronic myelogenous…
- October 26, 2022The Article related to p2x7 receptor antagonist blood retina barrier hyperglycemia diabetes retinopathy, blood retinal barrier, diabetic retinopathy, interleukin-1, p2x7…
- October 26, 2022The Article related to human chronic myeloid leukemia arterial thrombosis tyrosine kinase endothelium, bcr-abl tyrosine kinase inhibitor, atherosclerosis, cardiovascular, chronic…
- October 26, 2022The Article related to phenylquinazolinone preparation interleukin 6 proliferation inhibitor antiinflammatory cardiovascular, vascular cell adhesion mol 1 inhibitor phenylquinazolinone pyridopyrimidinone…
- October 26, 2022The Article related to tuberculosis drug resistance line probe assay namibia, xpert mtb/rif, diagnostics, multi-drug resistant, mycobacterium tuberculosis, mycobacterium tuberculosis…
- October 26, 2022The Article related to bosutinib drug safety toxicity philadelphia chromosome pos leukemia patient, bosutinib, cardiovascular events, chronic myeloid leukemia, clinical…
- October 26, 2022The Article related to anticancer ace inhibitor angiotensin receptor blocker thrombosis hypertension leukemia, arterial occlusive events, chronic myeloid leukemia, hypertension,…
- October 26, 2022The Article related to p2x7r mutation antagonist retina retinal ganglion glaucoma neuroprotection mouse, gpnm tyrp1 gene mutation p2x7 receptor antagonism…
- October 26, 2022The Article related to bosutinib dasatinib giitertinib ibrutinib anticancer agent cancer, dried blood microsampling, lc-ms/ms, therapeutic drug monitoring, tyrosine kinase…